Autoimmune encephalitis: Epidemiology, pathophysiology and clinical spectrum (part 2).
S Afr Med J
; 113(4): e875, 2023 04 04.
Article
en En
| MEDLINE
| ID: mdl-37283152
Autoimmune encephalitis (AE) represents a growing number of severe autoimmune-inflammatory diseases affecting both the white and grey matter of the brain. In part 1 of this series we focused on the epidemiology, pathophysiology and clinical presentation of this condition, with two illustrative cases. In this part, we will introduce the clinical criteria for AE, particularly for the diagnosis of anti-N-methyl-D-aspartate (NMDA) receptor encephalitis, which were developed to facilitate immune treatment in suspected cases before antibody results are available. We subsequently discuss the work up, differential diagnosis and treatment options for patients with this disease.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Hashimoto
/
Encefalitis Antirreceptor N-Metil-D-Aspartato
Tipo de estudio:
Diagnostic_studies
/
Screening_studies
Límite:
Humans
País/Región como asunto:
Africa
Idioma:
En
Revista:
S Afr Med J
Año:
2023
Tipo del documento:
Article
País de afiliación:
Sudáfrica
Pais de publicación:
Sudáfrica